Judge Denies Class Cert. In Antidepressant Marketing MDL

Law360, Los Angeles (February 5, 2013, 8:57 PM EST) -- A Massachusetts federal judge denied class certification Tuesday in three coordinated lawsuits alleging Forest Pharmaceuticals Inc. illegally promoted antidepressants Celexa and Lexapro for use in children, saying plaintiffs in two cases didn’t adequately represent their classes and another hadn’t shown common issues predominated.

In one ruling in the multidistrict litigation over the drugs, U.S. District Judge Nathaniel M. Gorton denied September motions for certification in a consolidated class action consisting of two 2009 lawsuits brought by plaintiffs in Missouri and New York federal courts, ruling they...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.